Vaccinex joins coronavirus-stoked rally, up 39% 
 Ultra-thinly traded micro cap Vaccinex (VCNX ) jumps on a 29x surge in volume, a modest 152K shares, apparently joining the coronavirus rally.

Investors appear to be ignoring the fact that the company is developing therapeutic vaccines for cancer, neurodegenerative diseases and autoimmune disorders.